Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Bear LLP
Novartis’ Gilenya Patent Invalidated as Obvious
On April 12, 2017, the Federal Circuit affirmed the determination by the US Patent and Trademark Office (USPTO), Patent Trial and Appeal Board (Board) that the claims of U.S. Patent No. 8,324,283 (“the ’283 patent”) were invalid as obvious. According to public databases, Novartis AG is the assignee of the ’283 patent, directed to pharmaceutical compositions for the treatment of multiple sclerosis.
Ingestible e-Pill Approved For Use in Hospitals
BodyCap, a France-based company said to be dedicated to the development of miniature wireless electronic sensors, recently announced that its e-Celsius® device has earned CE mark approval and is now commercially available for hospital use. The device will be available in the European Economic Area, Iceland, Liechtenstein and Norway.
2016 Security of Things® Forum
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
FDA Announces International Draft Guidance for Clinical Evaluation of Software as a Medical Device
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Sanofi & Verily Launch a Diabetes Joint Venture
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Tiffany Wins the Generic Battle, and the Spoils of War are Significant
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Supreme Court Will Not Review Pay-For-Delay Case over GSK’s Lamictal
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Chevrons, Stripes, Cheerleaders, and Copyright: The Supreme Court Hears Oral Argument in Star Athletica v. Varsity Brands
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Appeal of Final Refusal Maintaining that Human Jewelry is “Closely Related” to Pet Accessories
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Federal Circuit Review | October 2016
Withdrawal of Claims During Prosecution Can Trigger Prosecution History Estoppel In UCB, Inc. v. Yeda Research and Development Co., Ltd., Appeal No. 2015-1957, the Federal Circuit held that prosecution estoppel can apply even absent narrowing of a particular proposed claim.
Getting the Most from Biotech Patents in Europe Without Breaking the Bank: Selecting the Right Countries for Validation
Once a European patent application has been granted, all patentees must then choose to validate the granted application in one or more European countries. Such a decision may have long-term business and legal consequences. Upon payment of the grant fees to the European Patent Office, patentees will be awarded a European patent. The European patent is unenforceable until it becomes validated in the selected countries of the European Patent Convention.
Federal Circuit Distinguishes its Recent McRO Decision
Less than a month after reversing the lower court’s determination of invalidity in McRO, Inc. v. Bandai Namco Games America, Inc., the Federal Circuit has now upheld the invalidity of claims in FairWarning IP, LLC v. Iatric Systems, Inc. that, like McRO, recite computer-implemented application of rules. The court’s rationale in distinguishing the claims of these two patents, resulting in the different outcomes, is instructive to both patentees and patent challengers.
Overcoming 101 Rejections in the 3600 Technology Center
Patent applicants whose applications have been assigned to the USPTO Technology Center 3600 have been particularly impacted by the Supreme Court’s June 2014 decision in Alice Corp. v. CLS Bank Int'l. However, overcoming 101 rejections for applications assigned tothe TC 3600 is still achievable. A good example is U.S. Patent No. 9,444,932, issued in September, 2016.
Court Holds That Fashion Designer Karen Millen Cannot Use Her Name in Connection with Future Clothing Lines
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
MHRA Updates Guidance on Healthcare Apps as Medical Devices
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Medical Device Investor Forum - Oct. 27-28 in Irvine, CA - Knobbe Medical
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
10 Intellectual Property Pitfalls Every Startup Should Avoid
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Federal Circuit Finds Three Intellectual Venture’s Patents Invalid under the Mayo/Alice Framework
The Federal Circuit recently decided a case concerning three patents owned by Intellectual Ventures I LLC (“IV”). Intellectual Ventures I LLC v. Symantec Corp., Case Nos. 2015-1769, 2015-1770, 2015-1771 (Fed. Cir. Sept. 30, 2016). The district court had invalidated U.S. Patent Nos. 6,460,050 (‘050) and 6,073,142 (‘142) and found that Claim 7 of U.S. Patent No. 5,987,610 (‘610) was patent eligible. The district court had also found that Symantec Corp.
Using Pop Culture References in Advertisements? Just Do It Right
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Medtronic v. Robert Bosch - Has the Federal Circuit closed the door on reviewing IPR institution decisions?
On October 20, 2016, the Federal Circuit issued yet another opinion finding that the Patent Trial and Appeal Board’s decisions related to the institution of an inter partes review (IPR) are not subject to judicial review.
The Supreme Court’s Decisions Not to Hear Patent Cases Leaves Federal Circuit Decisions on Key Questions Intact
The Supreme Court recently declined to hear several patent cases, thus leaving the decisions by the Federal Circuit intact.
Johnson and Johnson Insulin Pump Potentially Vulnerable to Cyber Attack
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
FDA Planning Board Emphasizes Use of Data Sharing in Medical Device Monitoring
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Federal Circuit invalidates Affinity’s content-delivery patents for failing to disclose implementation of claimed functions
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Johnson & Johnson to Acquire Abbott Medical Optics
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Trademark Review | September 2016
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Inter Partes Review - Petitioner Estoppel under 35 U.S.C. §315(e)(1)
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Strategies For Aggressively Building A Patent Portfolio
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Software Patent Eligibility: Preemption Gets Starring Role at the Federal Circuit
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Third Circuit Upholds Dismissal of Doryx ‘Product Hopping’ Suit
On September 28, 2016, the Third Circuit issued an opinion in Mylan v.
Subject Matter Eligibility May Rest on Whether Software is “Technological”
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Stryker’s String of Acquisitions Continues with Ivy Sports Medicine
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Federal Circuit Relies on Robust Disclosure to Save Priority Date
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
FDA Will Hold Hearing on Communications Regarding Unapproved Uses
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Nestlé Continues Medical Industry Expansion
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Aralez’s YOSPRALA wins FDA approval
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Federal Circuit emphasizing “how” over “what.” But is that really enough?
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Navigating 101 Eligibility - Waypoints from the Federal Circuit
“As she said these words her foot slipped, and in another moment, splash! she was up to her chin in salt water….'I wish I hadn't cried so much!' said Alice, as she swam about, trying to find her way out.” Lewis Carroll, (1865) Applicants embarking on the journey of preparing and prosecuting a patent application can have a difficult time navigating the ever changing legal waters.
“World’s Smallest Pacemaker” Experiences Sizeable Success
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Continental patents a la carte or prix fixe? Biotechnology considerations for the unitary patent in Europe
The European unitary patent and Unitary Patent Court (UPC) are slated to go into effect in early 2017. These monumental changes will have a significant impact on the ways patent rights are obtained and enforced in Europe.
Federal Circuit Review | August 2016
Federal Circuit Holds That Using A Contract Manufacturer Does Not Trigger An On-Sale Bar In The Medicines Co. v. Hospira, Inc., Appeal Nos. 2014-1469, -1504, the Federal Circuit, en banc, held that the patentee’s deal for pharmaceutical manufacturing services did not trigger an on-sale bar under 35 U.S.C. § 102(b). The Medicines Co. (“MedCo”) contracted with Ben Venue to manufacture commercial quantities of Angiomax, a product that practiced the claims of MedCo’s asserted patents.
New USPTO Subject Matter Eligibility Guidance Following CellzDirect and Sequenom
On July 14, 2016, the U.S. Patent and Trademark Office issued new subject matter eligibility guidance for life science claims following a ruling by the Federal Circuit in Rapid Litigation Management v. CellzDirect, No. 15-1570 (Fed. Cir. July 5, 2016), and the Supreme Court’s decision to deny certiorari in Sequenom v. Ariosa, (788 F.3d 1371 (Fed. Cir. 2015) (cert. denied).
FDA Reaches Agreement with Industry for Reauthorization of Medical Device User Fees
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
U.S. Appeals Court Finds a Software Patent Valid Even Under the Supreme Court’s “Alice” Test
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
University of Minnesota Sues Gilead Sciences for Infringement of Hepatitis C Patents
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Hackers Steal 600K Records from Health Care Firms - Could Your Wearable Device Be Next?
Security firm InfoArmor published a report in late July 2016 stating that a group of attackers infiltrated American health care institutions, stole at least 600,000 patient records and attempted to sell more than 3 terabytes of that associated data. In an interview with eWeek, chie f intelligence officer Andrew Komarov noted that the hackers he investigated were able to compromise different health care institutions such as private clinics, vendors of medical equipment, and suppliers.
Scheduling an Appointment with Dr. Wearable Device
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Federal Circuit Finds Life Sciences Subject Matter Patent Eligible
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
#RIO, #SUPERBOWL, #FAIRUSE?
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Increase in Funding to Med Device Startups
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign up to create your digest using LinkedIn* By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Bear
Contact Bear, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack